Recombinant Saccharomyces cerevisiae Uncharacterized protein YOR032W-A (YOR032W-A)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: We will prioritize shipping the format that we have in stock. However, if you have any specific requirements for the format, please indicate them in your order. We will accommodate your request as much as possible.
Lead Time
Delivery time may vary depending on the purchasing method and location. Please consult your local distributors for specific delivery timeframes.
Note: All our proteins are shipped with standard blue ice packs by default. If you require dry ice shipment, please inform us in advance, as additional fees will apply.
Notes
Repeated freezing and thawing is not recommended. For optimal use, store working aliquots at 4°C for up to one week.
Reconstitution
We recommend centrifuging the vial briefly before opening to ensure the contents settle to the bottom. Please reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. We suggest adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard final concentration of glycerol is 50%. Customers can use this as a reference.
Shelf Life
The shelf life is influenced by several factors, including storage conditions, buffer ingredients, temperature, and the protein's inherent stability.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is recommended for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type will be determined during the manufacturing process.
The tag type will be determined during the production process. If you have a specific tag type preference, please communicate it to us, and we will prioritize developing the specified tag.
Synonyms
YOR032W-A; Uncharacterized protein YOR032W-A
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-66
Protein Length
full length protein
Species
Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)
Target Names
YOR032W-A
Target Protein Sequence
MRRALFIAGQTYLWLNLTHLLLIFSWSSTMAFSQSRRLLTPTVPCPTLLGIDFLILVLRH FDEIFI
Uniprot No.

Target Background

Database Links
Subcellular Location
Membrane; Multi-pass membrane protein.

Q&A

What is currently known about the YOR032W-A protein structure and expression?

YOR032W-A is a small protein consisting of 66 amino acids expressed in Saccharomyces cerevisiae . While the protein has been recombinantly produced with a His-tag in E. coli expression systems, detailed structural information remains limited . The protein is classified as "uncharacterized," indicating insufficient experimental evidence to assign a specific biological function.

To investigate its structure, researchers should consider employing:

  • Circular dichroism spectroscopy to determine secondary structure elements

  • Nuclear magnetic resonance (NMR) spectroscopy for small proteins under 20 kDa

  • X-ray crystallography if the protein can be successfully crystallized

  • In silico structure prediction using tools like AlphaFold

For expression analysis, quantitative RT-PCR comparing expression levels across different growth conditions and cell cycle phases would provide insights into potential regulatory patterns.

How can researchers confirm the existence and expression of YOR032W-A in yeast cells?

Confirming the expression of uncharacterized proteins like YOR032W-A requires multiple complementary approaches:

  • Transcriptional verification:

    • RNA-seq analysis to confirm transcription under various conditions

    • RT-PCR with gene-specific primers to verify mRNA expression

    • Northern blotting to determine transcript size and abundance

  • Protein-level verification:

    • Western blotting using antibodies against epitope-tagged versions of YOR032W-A

    • Mass spectrometry analysis of cellular protein extracts

    • Creating fluorescent protein fusions (GFP-YOR032W-A) to visualize expression

Many uncharacterized yeast genes lack conclusive evidence of functionality despite being annotated as genes . Therefore, confirming expression is a crucial first step before investing in functional characterization.

What expression systems are most effective for producing recombinant YOR032W-A protein?

Based on available data, E. coli has been successfully used as a host for recombinant YOR032W-A expression with His-tag purification . For optimal expression, researchers should consider:

  • E. coli expression considerations:

    • Using BL21(DE3) or Rosetta strains to address codon bias

    • Testing multiple fusion tags (His, GST, MBP) to improve solubility

    • Optimizing induction conditions (temperature, IPTG concentration, induction time)

  • Yeast expression alternatives:

    • Homologous expression in S. cerevisiae under native or galactose-inducible promoters

    • Pichia pastoris for potentially higher yields of secreted protein

    • Evaluation of codon-optimization if using heterologous hosts

  • Purification strategy:

    • Immobilized metal affinity chromatography (IMAC) for His-tagged proteins

    • Size exclusion chromatography for final polishing

    • Assessing protein stability in various buffer conditions

A systematic comparison of expression levels and protein solubility across different systems would determine the optimal approach for obtaining sufficient quantities of functional protein for downstream analyses.

What methods are most effective for determining the cellular localization of YOR032W-A?

Determining the subcellular localization of YOR032W-A would provide valuable clues to its function:

  • Fluorescent protein fusion approaches:

    • C-terminal and N-terminal GFP fusions (testing both to ensure functionality)

    • Time-lapse microscopy to track potential dynamic localization changes

    • Co-localization with known organelle markers

  • Biochemical fractionation:

    • Differential centrifugation to separate cellular compartments

    • Western blotting of fractions with antibodies against tagged YOR032W-A

    • Mass spectrometry analysis of purified organelles

  • Immunolocalization:

    • Generation of antibodies against purified recombinant YOR032W-A

    • Immunofluorescence microscopy with appropriate fixation protocols

    • Immunogold electron microscopy for high-resolution localization

It's important to note that even localization data alone does not definitively determine function but can substantially narrow the range of potential biological roles and direct subsequent experimental approaches .

What bioinformatic approaches can predict potential functions of YOR032W-A?

Computational prediction approaches provide valuable starting points for experimental validation:

  • Sequence-based analyses:

    • Multiple sequence alignment with orthologs from related species

    • Identification of conserved domains using InterPro, Pfam, or SMART

    • Analysis of predicted structural motifs suggestive of specific functions

  • Network-based predictions:

    • Integration of protein-protein interaction data from high-throughput studies

    • Co-expression analysis with functionally characterized genes

    • Guilt-by-association approaches examining genes with similar expression patterns

  • Evolutionary analyses:

    • Phylogenetic profiling to identify co-evolving genes

    • Examination of selection pressures on YOR032W-A sequence

    • Synteny analysis to identify conserved genomic context

While bioinformatic predictions are valuable, previous analyses have shown that for uncharacterized yeast proteins, computational predictions achieve only moderate success rates, with one study finding that only 23 out of 82 subsequently characterized proteins matched their computational predictions .

How can researchers design effective deletion or knockdown experiments to assess YOR032W-A function?

The small size and uncharacterized nature of YOR032W-A requires careful experimental design:

  • Gene deletion approaches:

    • CRISPR-Cas9 targeted deletion with appropriate controls

    • Homologous recombination-based knockout with selectable markers

    • Verification of deletion by PCR and sequencing

  • Phenotypic analysis of deletion strains:

    • Growth rate measurements under various conditions (temperature, carbon sources, stress)

    • Microscopic examination of morphological changes

    • High-throughput phenotypic assays (e.g., Biolog plates)

  • Conditional expression systems:

    • Tetracycline-repressible promoters for controlled gene expression

    • Auxin-inducible degron tags for rapid protein depletion

    • Temperature-sensitive alleles if structural information allows rational design

  • Genetic interaction screening:

    • Synthetic genetic array (SGA) analysis to identify genetic interactions

    • Multicopy suppressor screens to identify related pathway components

    • Chemical-genetic profiling to identify conditions where YOR032W-A becomes essential

Researchers should be aware that approximately 80% of yeast gene deletions show no obvious phenotype under standard laboratory conditions, necessitating examination under diverse environmental conditions .

How can transcriptome analysis be used to investigate the function of uncharacterized proteins like YOR032W-A?

Transcriptomic approaches provide valuable insights into the cellular consequences of manipulating YOR032W-A:

  • Differential expression analysis:

    • RNA-seq comparing wild-type and YOR032W-A deletion strains

    • Time-course analysis following induction/repression of YOR032W-A

    • Comparison across multiple environmental conditions

  • Data analysis approaches:

    • Gene set enrichment analysis (GSEA) to identify affected pathways

    • Co-expression network construction to place YOR032W-A in functional modules

    • Comparison with transcriptional responses to known perturbations

  • Integration with other datasets:

    • Correlation with existing transcriptome data from silver nanoparticle treatment

    • Analysis of transcriptional changes in cell wall and ribosome biogenesis genes, which are commonly affected in many perturbations

    • Examination of mitochondrial and cell membrane integrity genes often altered in stress responses

Recent transcriptome studies in yeast have demonstrated that genes involved in rRNA processing, ribosome biogenesis, cell wall formation, and mitochondrial functions often show coordinated expression changes in response to various perturbations .

What protein-protein interaction methods are most suitable for identifying YOR032W-A binding partners?

Identifying interacting partners provides critical insights into protein function:

  • Affinity purification approaches:

    • Tandem affinity purification (TAP) tagging of YOR032W-A

    • Co-immunoprecipitation with epitope-tagged YOR032W-A

    • BioID or APEX2 proximity labeling to identify neighboring proteins

  • Yeast two-hybrid screening:

    • Construction of bait plasmids with YOR032W-A

    • Screening against genomic or cDNA libraries

    • Confirmation of interactions by co-immunoprecipitation

  • In vitro interaction assays:

    • Pull-down assays with recombinant His-tagged YOR032W-A

    • Surface plasmon resonance for quantitative binding analysis

    • Crosslinking mass spectrometry to map interaction interfaces

  • Data analysis considerations:

    • Filtering of common contaminants and false positives

    • Network analysis to identify protein complexes

    • Integration with existing interaction datasets

Given that YOR032W-A is a small protein (66 amino acids), researchers should be particularly attentive to potential artifacts in interaction studies and employ multiple complementary approaches for validation.

How can researchers address contradictory data when characterizing YOR032W-A function?

The functional characterization of uncharacterized proteins often produces seemingly contradictory results:

  • Systematic validation approaches:

    • Replication in multiple genetic backgrounds to control for strain effects

    • Testing under diverse environmental conditions

    • Using complementary methodological approaches

  • Reconciliation strategies:

    • Consideration of protein multifunctionality (moonlighting proteins)

    • Analysis of condition-specific functions

    • Examination of potential post-translational modifications affecting function

  • Addressing discrepancies between high-throughput and targeted studies:

    • Validation of high-throughput findings with directed experiments

    • Assessment of statistical significance and effect sizes

    • Evaluation of technical limitations in different experimental approaches

  • Data integration framework:

    • Bayesian integration of multiple evidence types

    • Weighting evidence based on methodological rigor

    • Formal meta-analysis when sufficient data are available

Previous analyses have shown that predictions of gene function supported by three or more large-scale datasets still achieve only moderate success rates in correctly identifying protein function .

Can recombinant S. cerevisiae expressing YOR032W-A be utilized in immunotherapy approaches?

While YOR032W-A itself has not been specifically studied for immunotherapy applications, recombinant S. cerevisiae has demonstrated promise as an immunotherapeutic vector:

  • Potential immunotherapy applications:

    • Whole yeast cells expressing target proteins can activate dendritic cells and generate T-cell responses

    • Heat-killed recombinant yeast can serve as vectors engineered to express target proteins

    • Such approaches have been evaluated in cancer immunotherapy contexts

  • Advantages of yeast-based immunotherapy platforms:

    • Efficient manufacturing processes

    • Not neutralized by antibodies, allowing for both priming and boosting

    • Do not require patient-specific approaches

  • Considerations for YOR032W-A application:

    • Function would need to be characterized before therapeutic relevance could be established

    • Immunogenicity testing would be required

    • Regulatory considerations for uncharacterized proteins

The GI-4000 product series using recombinant S. cerevisiae has demonstrated favorable safety profiles in clinical trials, suggesting that yeast-based expression systems have potential for immunotherapeutic applications .

What methodologies can determine if YOR032W-A affects cell wall integrity or stress responses?

Examining cell wall integrity and stress responses is particularly relevant given the prevalence of these pathways in transcriptome studies of yeast:

  • Cell wall integrity assessment:

    • Sensitivity testing to cell wall-perturbing agents (Congo Red, Calcofluor White)

    • Analysis of β-glucan and chitin content

    • Activation measurement of the cell wall integrity pathway (Slt2/Mpk1 phosphorylation)

  • Transcriptional response analysis:

    • qRT-PCR for cell wall integrity pathway target genes

    • Comparison with transcriptome profiles from known cell wall stressors

    • Analysis of genes like TIR1 and DAN1 that have been validated in stress response studies

  • Stress response assessment:

    • Growth assays under various stress conditions (oxidative, osmotic, temperature)

    • Measurement of reactive oxygen species production

    • Analysis of mitochondrial function and integrity

Transcriptome studies have shown that exposure to sublethal amounts of silver nanoparticles affects numerous cellular processes in yeast, including cell wall formation and plasma membrane integrity . Similar comprehensive approaches could reveal if YOR032W-A plays a role in these fundamental cellular processes.

How can genome-wide approaches help characterize the function of YOR032W-A?

Systems biology offers powerful tools for understanding uncharacterized proteins:

  • Genome-wide genetic interaction mapping:

    • Synthetic genetic array (SGA) analysis with YOR032W-A deletion

    • E-MAP (Epistatic Mini Array Profile) to identify quantitative genetic interactions

    • CRISPR-based genetic interaction screens

  • Integration with existing datasets:

    • Comparison with genetic interaction profiles of characterized genes

    • Cluster analysis to identify genes with similar interaction patterns

    • Network-based function prediction

  • Metabolomic approaches:

    • Untargeted metabolomics comparing wild-type and YOR032W-A mutants

    • Flux balance analysis to identify altered metabolic pathways

    • Integration of metabolomic and transcriptomic data

  • Computational frameworks:

    • Bayesian network models integrating multiple data types

    • Machine learning approaches trained on characterized genes

    • Global fitness analysis across diverse environmental conditions

The integration of multiple high-throughput datasets has been shown to improve functional prediction accuracy, though caution is warranted as predictions might best serve as general guides rather than precise functional assignments .

What approaches can determine if YOR032W-A is involved in RNA processing or ribosome biogenesis?

Given the prevalence of RNA processing and ribosome biogenesis genes among previously uncharacterized yeast proteins:

  • Ribosome profiling analysis:

    • Comparison of translation efficiency in wild-type and YOR032W-A mutants

    • Analysis of ribosome assembly intermediates by sucrose gradient fractionation

    • Pulse-chase labeling of rRNA processing

  • RNA processing assessment:

    • Northern blot analysis of rRNA processing intermediates

    • CRAC (crosslinking and cDNA analysis) to identify RNA binding sites

    • RNA immunoprecipitation to identify associated RNA species

  • Functional assays:

    • Polysome profiling to assess global translation status

    • In vitro reconstitution assays with purified recombinant YOR032W-A

    • Genetic interaction analysis with known ribosome biogenesis factors

  • Localization studies:

    • Co-localization with nucleolar or ribosomal markers

    • Electron microscopy to visualize potential association with ribosomes

    • Fractionation studies to determine association with pre-ribosomes

Previous functional characterization of uncharacterized yeast proteins has revealed that RNA processing and ribosome biogenesis are among the most common functions discovered , making this a high-priority area for investigation.

What research strategies have proven most successful in characterizing previously unknown yeast proteins?

Based on historical progress in characterizing yeast proteins:

  • Successful methodological approaches:

    • Integration of multiple data types rather than reliance on single approaches

    • Focused hypothesis testing based on preliminary high-throughput results

    • Phenotypic analysis under diverse environmental conditions

    • Genetic interaction mapping to place genes in functional pathways

  • Common pitfalls to avoid:

    • Over-reliance on single high-throughput datasets

    • Neglecting condition-specific functions

    • Focusing exclusively on standard laboratory conditions

    • Failure to validate high-throughput results with targeted experiments

  • Resource prioritization:

    • Focusing on proteins conserved across species for broader impact

    • Prioritizing proteins with genetic interactions to essential genes

    • Examining proteins with expression patterns correlated to characterized pathways

Previous analyses have shown that of 122 proteins with predicted functions based on multiple data sources, only 23 were eventually assigned to the precise predicted categories, indicating the need for comprehensive experimental validation beyond computational predictions .

How can the methodologies used to study YOR032W-A be applied to other uncharacterized proteins in yeast and other organisms?

The approaches outlined for YOR032W-A provide a framework applicable to other uncharacterized proteins:

  • Generalizable methodology framework:

    • Sequential approach from basic characterization to advanced functional studies

    • Integration of computational predictions with experimental validation

    • Application of multiple complementary experimental approaches

    • Systematic condition testing to identify context-dependent functions

  • Cross-species applications:

    • Identification of orthologs in model organisms with different experimental advantages

    • Comparative analysis of conserved vs. species-specific functions

    • Leveraging of cross-species complementation to test functional conservation

  • Technology transfer considerations:

    • Adaptation of yeast methods to other microbial or mammalian systems

    • Scaling considerations for larger and more complex genomes

    • Development of computational tools for integrating heterogeneous data across species

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.